Go to content
You are here:
Home
Publications
Icatibant (Firazyr) for the treatment of hereditary angio-oedema (HAE)
Search within English part of National Health Care Institute
Search
Icatibant (Firazyr) for the treatment of hereditary angio-oedema (HAE)
This report is a summary of recommendations by Zorginstituut Nederland. The original text is in Dutch.
Download "Icatibant (Firazyr) for the treatment of hereditary angio-oedema (HAE)"
PDF document | 82 kB
Report | 24-10-2010
Share this page
Share this page on your X account
Share this page on your Facebook account
Share this page on your LinkedIn account